Abstract
Raltitrexed is a specific inhibitor of thymidylate synthase, and has been confirmed that raltitrexed has no cross tolerance with 5-fluorouracil. Studies have shown that raltitrexed-based combination chemotherapy has a beneficial effect on the treatment of advanced gastric cancer, and well tolerance, which is worthy of clinical use. Key words: Stomach neoplasms; Drug therapy; Raltitrexed
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
